Stay updated on Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial

Sign up to get notified when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    No Change Detected
  5. Check
    7 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:51:37.000Z thumbnail image
  6. Check
    14 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update or modification in the context of a phase 2 trial involving gemcitabine, cisplatin, and nivolumab as neoadjuvant therapy for patients with muscle-invasive bladder cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:27:03.000Z thumbnail image
  7. Check
    19 days ago
    Change Detected
    Summary
    The value 'No Posted' on the webpage has recently changed to 'Submitted.' This change likely indicates that the publication or documentation related to medical and healthcare has been submitted for review or publication.
    Difference
    0.2%
    Check dated 2024-06-01T11:39:32.000Z thumbnail image
  8. Check
    29 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.' This change provides a more detailed explanation of the eligibility criteria for participation in the study.
    Difference
    42%
    Check dated 2024-05-22T21:23:43.000Z thumbnail image
  9. Check
    49 days ago
    Change Detected
    Summary
    The value (Estimated) on the webpage has recently changed to . This change likely indicates an update or revision in the estimated information related to medical and healthcare publications and documentation.
    Difference
    0.1%
    Check dated 2024-05-02T03:40:38.000Z thumbnail image
  10. Check
    50 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:51:40.000Z thumbnail image

Stay in the know with updates to Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.